Otamixaban

CAS No.

193153-04-7

MDL No.

N/A

C₂₅H₂₆N₄O₄

446.50

InChI Key

PFGVNLZDWRZPJW-OPAMFIHVSA-N

Pack Size	Purity	Price	Availability
2 mg	To Be Confirmed	$347	In Stock
5 mg	98.08%	$763	In Stock
10 mg	98.08%	$1182	In Stock
25 mg	98.08%	$2243	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

2 mg

To Be Confirmed

$347

In Stock

5 mg

98.08%

$763

In Stock

10 mg

98.08%

$1182

In Stock

25 mg

98.08%

$2243

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	193153-04-7
Product Name	Otamixaban

Biological Targets

F10

Associated Conditions

kidney disease·liver disease·coronary artery disease·acute coronary syndrome

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Otamixaban

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure.

Pharmacokinetic/pharmacodynamic relationships for otamixaban, a direct factor Xa inhibitor, in healthy subjects.

Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, and acetylsalicylic acid.

Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide.

Documentation